Evidence map›Paper›PMID 37083953›Full record

ArticleDisease models & mechanisms2023

Probing the pathogenicity of patient-derived variants of MT-ATP6 in yeast.

Emilia Baranowska, Katarzyna Niedzwiecka, Chiranjit Panja, Camille Charles, Alain Dautant, Jarosław Poznanski, Jean-Paul di Rago, Déborah Tribouillard-Tanvier, Roza Kucharczyk

Open access · goldAbstract read
In one paragraph

Article in Disease models & mechanisms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Disease models of Leigh syndrome: From yeast to organoids.Journal of inherited metabolic disease · 2024
    Review
  4. Leber's hereditary optic neuropathy like disease inAmerican journal of ophthalmology case reports · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Emilia BaranowskaInstitute of Biochemistry and Biophysics, Polish Academy of Sciences, 02106 Warsaw, Poland.ORCID 0000-0001-7349-1400
Katarzyna NiedzwieckaInstitute of Biochemistry and Biophysics, Polish Academy of Sciences, 02106 Warsaw, Poland.ORCID 0000-0002-9482-3918
Chiranjit PanjaInstitute of Biochemistry and Biophysics, Polish Academy of Sciences, 02106 Warsaw, Poland.ORCID 0000-0001-8235-1426
Camille CharlesUniversity of Bordeaux, Centre National de la Recherche Scientifique, Institut de Biochimie et Génétique Cellulaires, UMR 5095, F-33000 Bordeaux, France.ORCID 0000-0002-2182-4928
Alain DautantUniversity of Bordeaux, Centre National de la Recherche Scientifique, Institut de Biochimie et Génétique Cellulaires, UMR 5095, F-33000 Bordeaux, France.ORCID 0000-0002-7145-278X
Jarosław PoznanskiInstitute of Biochemistry and Biophysics, Polish Academy of Sciences, 02106 Warsaw, Poland.ORCID 0000-0003-2684-1775
Jean-Paul di RagoUniversity of Bordeaux, Centre National de la Recherche Scientifique, Institut de Biochimie et Génétique Cellulaires, UMR 5095, F-33000 Bordeaux, France.ORCID 0000-0002-3766-9002
Déborah Tribouillard-TanvierUniversity of Bordeaux, Centre National de la Recherche Scientifique, Institut de Biochimie et Génétique Cellulaires, UMR 5095, F-33000 Bordeaux, France.ORCID 0000-0002-2290-5375
Roza KucharczykInstitute of Biochemistry and Biophysics, Polish Academy of Sciences, 02106 Warsaw, Poland.ORCID 0000-0002-8712-7535
Institute of Biochemistry and Biophysics, Polish Academy of Sciences · PLUniversité de Bordeaux · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The list of mitochondrial DNA (mtDNA) variants detected in individuals with neurodegenerative diseases is constantly growing. Evaluating their functional consequences and pathogenicity is not easy, especially when they are found in only a limited number of patients together with wild-type mtDNA (heteroplasmy). Owing to its amenability to mitochondrial genetic transformation and incapacity to stably maintain heteroplasmy, and the strong evolutionary conservation of the proteins encoded in mitochondria, Saccharomyces cerevisiae provides a convenient model to investigate the functional consequences of human mtDNA variants. We herein report the construction and energy-transducing properties of yeast models of eight MT-ATP6 gene variants identified in patients with various disorders: m.8843T>C, m.8950G>A, m.9016A>G, m.9025G>A, m.9029A>G, m.9058A>G, m.9139G>A and m.9160T>C. Significant defect in growth dependent on respiration and deficits in ATP production were observed in yeast models of m.8950G>A, m.9025G>A and m.9029A>G, providing evidence of pathogenicity for these variants. Yeast models of the five other variants showed very mild, if any, effect on mitochondrial function, suggesting that the variants do not have, at least alone, the potential to compromise human health.

Indexed as

Saccharomyces cerevisiaeDNA, MitochondrialHumansMitochondriaMitochondrial Proton-Translocating ATPasesMutationVirulenceDNA, MitochondrialMitochondrial Proton-Translocating ATPasesMT-ATP6 protein, humanATP synthaseLHONMILSMitochondrial diseasesMitochondrial DNA mutationMT-ATP6mtDNAYeast

Identifiers

PMID37083953
PMCPMC10151828
OpenAlexW4366603182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.